Biogenic Synthesis of MnO2 Nanoparticles With Leaf Extract of Viola betonicifolia for Enhanced Antioxidant, Antimicrobial, Cytotoxic, and Biocompatible Applications

In this study, we propose to synthesize NPs using plant extract containing active biomedical components, with the goal of obtaining NPs that inherit the biomedical activities of the plant. Herein, we report the synthesis of manganese dioxide nanoparticles (VBLE-MnO2 NPs) using the leaves extract of Viola betonicifolia, in which the biological active plant’s secondary metabolites function as both reducing and capping agents. The synthesized NPs were successfully characterized with different spectroscopic techniques. The antibacterial, antifungal, and biofilm inhibition properties of the synthesized VBLE-MnO2 NPs were further explored against a variety of bacteria (Gram-positive and Gram-negative) and mycological species. Additionally, their antioxidant ability against linoleic acid peroxidation inhibition, cytobiocompatibility with hMSC cells, and cytotoxicity against MCF-7 cells were investigated compared to leaves extract and chemically synthesized manganese dioxide NPs (CH-MnO2 NPs). The results were demonstrated that the synthesized VBLE-MnO2 NPs presented excellent antibacterial, antifungal, and biofilm inhibition performance against all the tested microbial species compared to plant leaves extract and CH-MnO2 NPs. Moreover, they also exhibited significant antioxidant potential, which was comparable to the external standard (ascorbic acid); however, it was higher than plant leaves extract and CH-MnO2 NPs. Furthermore, the synthesized CH-MnO2 NPs displayed good cytobiocompatibility with hMSC cells compared to CH-MnO2 NPs. The enhanced antioxidant, antibacterial, antifungal, and biofilm inhibition efficacy as compared to CH-MnO2 NPs might be attributed to the synergistic effect of the VBLE-MnO2 NPs’ physical properties and the adsorbed biologically active phytomolecules from the leaves extract of V. betonicifolia on their surface. Thus, our study establishes a novel ecologically acceptable route for nanomaterials’ fabrication with increased and/or extra medicinal functions derived from their herbal origins.


INTRODUCTION
Antibiotic and antifungal drug resistance in pathogenic bacterial and fungal species have emerged as an alarming threat globally . A significant reason behind the antimicrobial drugs not working is the formation of biofilms by these microbials (Khan et al., 2021c). These pathogenic microbials in biofilms form can withstand a thousand dosages of conventional antimicrobial medicines (Khan and Lee, 2020b). Moreover, these pathogenic microbials have also evolved resistance to antimicrobial drugs by developing efflux mechanisms, decreasing the cell wall permeation, modifying the drug targeted sites, etc. (Li and Nikaido, 2009;. Therefore, these antimicrobial drugs are failing to treat different infectious diseases caused by these pathogenic microbial species. The current death burden due to infectious disease caused by pathogenic microbials is around 0.7 million deaths annually, as per World Health Organization. This can be risen to approximately 10 million annually by 2050 if effective and novel antimicrobial agents are not developed ; New report calls for urgent action to avert antimicrobial resistance crisis, 2021). In this instance, nanotechnology has emerged and come to the forefront to confront antimicrobial resistance issues by developing nanosized materials.
NPs, among other nanomaterials, are attracting so much attention worldwide because of their unique physical characteristics. Moreover, NPs present excellent biological, electrical, sensing, and optoelectronics applications due to their physical characteristics. National Nanotechnology Initiative has spent more than 27 billion dollars in the United States during the last 10 years. Moreover, the European Commission has initiated HORIZON 2020 projects in the nanotechnology sector with around €1.1 billion. In Asia, China and Japan are investing vast amounts of resources and funds for nanoscience and nanotechnology, which resulted in prices rising by 20 percent nearly every year since 2003 (Ciorîță et al., 2020;Home National Nanotechnology Initiative 2021). Metals (Au, Ag, Pt, Pd, Mn, Zn, Cu, etc.) and metal oxides (CuO,MnO,ZnO,NiO,MgO,FeO,Fe 2 O 3 , Cr 2 O 3 , etc.) NPs are widely exploited and investigated for different biological application, such as antibacterial, antimycotic, antibiofilm, antioxidant, and anticancer (Abbasi et al., 2019a,b;Al-Radadi, 2019;Haq et al., 2020;Khan et al., ,b, 2021b. In contrast to traditional antibacterial and antifungal medicines, these NPs readily penetrate pathogenic microorganisms' cell walls and membranes due to their nanoscale size. This is a key element in the antimicrobial activities of these NPs . Furthermore, MnO 2 NPs have been much attracted due to their low potential cytotoxicity compared to others. Generally, NPs are produced through chemical or physical methods. However, both approaches need significant amounts of energy and hazardous chemicals for reduction and capping, and they are not readily scalable (Ciorîță et al., 2020;Khan et al., 2020a,b). A critical issue is that these methods jeopardize the biocompatibility of NPs owing to using dangerous chemicals in the manufacturing process, which remain on the NPs' interface also after repeated washing. As a result, their biological applicability is jeopardized (Negahdary et al., 2015;Ogunyemi et al., 2019;Ciorîță et al., 2020). Thus, the synthesis of NPs utilizing biological approaches, particularly those based on plants, offers a solution to these established methodologies (Ciorîță et al., 2020;Khan et al., 2020a,b). It has been shown that the phytochemical constituents present in plants, including, alkaloids, polyphenols, flavonoids, and terpenoids, induce the reduction of metal ions and eventual formation of metal NPs (Elbagory et al., 2019;Gharehyakheh et al., 2020). Moreover, it is considered that biogenic plant phytomolecules may enhance their intrinsic properties, such as antioxidant, antibacterial, and anticancer compared to extracts (Chandran et al., 2006;Kumar and Yadav, 2009;Muthukumar et al., 2016). Thus, biogenic synthesis using leaves extract of plants enhances the nanoparticle biocompatibility and is responsible for the synergetic effect .
In this regard, leaves extract of Viola betonicifolia (L.), a species of family Violaceace, was used for bioconversion of manganese ions to NPs. V. betonicifolia (L.) is naturally available in several countries over the globe, including Pakistan, India, Nepal, Sri Lanka, China, Malaysia, Burma, and Australia (Flora of Pakistan; Rizwan et al., 2019). This plant has been widely exploited as purgative, astringent, diaphoretic, anticancer, antipyretic, and employed for treating various diseases, such as nervous disorders, epilepsy, cough, skin disorders, blood disorders, sinusitis, pharyngitis kidney diseases, bronchitis, and pneumonia (Iqbal and Hamayun, 2005;Rizwan et al., 2019). Various reports demonstrated that the whole leaves extract of V. betonicifolia is a rich source of several biogenic phytomolecules, including alkaloids, flavonoids, tannins, phenolic compounds, saponins, and triterpenoids with various biological applications (Muhammad et al., 2012(Muhammad et al., , 2013a. Almost 200 natural active compounds have been identified and isolated from various Viola species (Zhu et al., 2015). Up to now, many plants have been utilized for the biogenic synthesis of MnO 2 NPs; however, there is no report for the utilization of V. betonicifolia (L.). Therefore, here for the first time, we report the biogenic synthesis of MnO 2 NPs using V. betonicifolia (L.) leaves extract. Further considering the leaf leaves extract of V. betonicifolia health benefits in the biomedical field, herein, biologically synthesized MnO 2 NPs were evaluated for antimicrobial, anticancer, and antioxidant activities.

MATERIALS AND METHODS
All the chemicals used in this work were purchased from Sigma Chemicals Co (St, Louis, MS, United States) and Merck (Darmstadt Germany) and were analytical grade. The commercially available MnO 2 NPs were purchased from US Research Nanomaterials, Inc. with 30-50 nm size for comparative biological analysis. These NPs are called as CH-MnO 2 NPs.

Collection of the Plant Material
The fresh V. betonicifolia leaves were collected from the surrounding areas of Lahore, Pakistan. Dr. Zaheer-ud-Din Frontiers in Microbiology | www.frontiersin.org Khan (Department of Botany, GC University, Pakistan) made its identification. The voucher specimen (V. betonicifolia: GC. Herb. Bot. 213) of plant was deposited at the herbarium of the Department of Botany, GC University, Lahore, Pakistan, and further study approval is not required as per regional guidelines.

Preparation of Leaves Extract of Viola betonicifolia
The leaves extract of V. betonicifolia was prepared by taking 20 g of fresh leaves of V. betonicifolia. The leaves were washed thoroughly with deionized (DI) water to remove any impurities and dust and air-dried at 30°C. The dried leaves were cut into small pieces, pulverized with the help of a commercial blender, and the resulting plant's leaves powder was transferred to a 500 ml beaker. The 150 ml of DI water was then added and stirred at 60°C for 60 min. After, the obtained leaves extract of V. betonicifolia was cooled down to room temperature and then filtered. The filtrate was collected and stored at 4°C in an airtight glass bottle for further use (Figure 1).

Biogenic Synthesis of Manganese Dioxide NPs (VBLE-MnO 2 NPs)
For the biogenic synthesis of manganese dioxide NPs, 1 mm of Manganese acetate was added to 25 ml of leaves extract of V. betonicifolia (Figure 1). The resulting mixture was heated at 40°C for 70 min with continuous stirring at pH 7.15. After, the synthesized manganese dioxide NPs were separated by centrifugation at 3000 rpm for 30 min from the reaction mixture. After centrifugation, the obtained NPs were washed with DI/ ethanol three times and then dried in an oven at 40°C and further calcined in a muffle furnace at 200°C for 3 h. Finally, the green synthesized manganese dioxide NPs were stored in a glass bottle for further characterization and named as VBLE-MnO 2 NPs.

X-ray Diffraction
The crystalline nature and phase purity of the green synthesized VBLE-MnO 2 NPs were determined using the powder X-ray diffraction spectroscopy (XRD), which was carried out at a wavelength (λ) of 0.154 nm with LYNXEYE XE-T detector (Haidian, Beijing, China) in a Bruker D2 PHASER. The XRD spectra were recorded in the 2θ range 20-60°, with a scanning rate of 1°/min and a slit width of 6.0 mm.

Energy-Dispersive X-ray Spectroscopy
The chemical composition of synthesized VBLE-MnO 2 NPs was performed with an energy-dispersive X-ray (EDX) spectroscopy and Thermo Fisher Scientific Ultradry (Madison, WI, United States) which was attached with SEM.

Transmission Electron Microscope
Transmission electron microscopy (TEM) images of the green synthesized VBLE-MnO 2 NPs were obtained using a Tecnai F 12 microscope (FEI/Philips Tecnai 12 BioTWIN, Baltimore, MD, United States) operating at an acceleration voltage of 200 kV (Devi et al., 2019;Khan et al., 2021b). For TEM analysis, the samples were mixed in methanol and then sonicated at 25-30°C. Then, specimens were deposited into a carbon-coated copper grid. After removing the excess solution, the copper grid was left to dry for 5-10 min. Zetasizer Dynamic Light Scattering The stability and the particle size distribution of the fabricated VBLE-MnO 2 NPs were measured at 25-30°C, with a particle size analyzer (Malvern Zetasizer Nano ZS, Worcestershire, WR14 1XZ, United Kingdom; Devi et al., 2019;Khan et al., 2021b).

Antibacterial Propensity
The antibacterial propensity of the synthesized VBLE-MnO 2 NPs was evaluated on Klebsiella pneumoniae ATCC ® 700603™ and Staphylococcus aureus ATCC ® 23235™, by using serial dilution method (Khan et al., 2021a). In general, the strains of bacteria were seeded into separate blood agar plates and then cultured for 24 h at 37°C. After several bacterium colonies were grown on the plates, they were diluted with phosphate buffer saline (PBS). Their cell density was maintained to 1 × 10 8 colony forming units (CFU) per ml. Following that, 10 μl of each bacterial culture was separately added to wells of a 24-well microtiter plate with 1.0 ml of Mueller-Hinton broth (MHB). For each well, the final concentration of each bacterium was 1 × 10 6 CFU/ml. A 50 μl of each sample solution at 250 μg/ml concentration was then transferred to separate wells and incubated at 37°C for 24 h. The bacterial species were then counted in the wells using the serial dilution plate counting method. The antibacterial propensity was expressed in the form of log 10 reduction in bacterial growth and % killing using the following formulas: log l og log 10 10 10 here, CFU B and CFU A are the CFU of bacterial strains before and after 24 h of incubation, respectively, with the treatment of sample solutions.

Live/Dead Bacteria Staining Assay
Live and dead bacterial staining assay was carried out using a confocal laser scanning microscope (CLSM, FV-1200, Olympus, Tokyo, Japan) to confirm the antibacterial activity of green synthesized VBLE-MnO 2 NPs. The assay was performed following the methods reported by Choi et al. (2017). Briefly, two nucleic dyes, Hoechst 33342 (membrane-permeant) and propidium iodide (PI; membrane-impermeant), were used for staining the live (green) and dead (red) bacteria, respectively. Each bacterium was cultured in nutrient broth in an orbital shaker for 24 h at 37°C to reach the stationary phase, which was consists of approximately 10 5 -10 6 colony forming units (CFU) per ml. After incubation, each bacteria strain was inoculated into sterilized cover glass coated with poly-L-lysine in a 24-well plate and then incubated for 1 h for bacterial cells attached to the cover glass. The suspended bacterial cells were then discarded, and each cover glass was gently rinsed three times with a saline solution. For the treatment, each bacterium cells on the cover glass were incubated with green synthesized VBLE-MnO 2 NPs (250 μg/ml) and then incubated for 24 h at 37°C. Bacteria cells on cover glass were then stained with an alive and dead bacterial viability kit in accordance with the manufacturer's recommendations. Dead and live bacterial cells were analyzed with CLSM using an excitation wavelength of 493 nm and 350 for PI and Hoechst 33342 and an emission wavelength of 636 nm and 461 nm for PI and Hoechst 33342, respectively. We only considered green synthesized VBLE-MnO 2 NPs for live/dead staining assay as they presented excellent antibacterial properties in terms of Log 10 reductions.

ROS Generation Investigation in the Nanoparticles-Treated Bacteria
The CellROX ® Green staining was further used to examine the death of bacterial species caused by intracellular ROS production. In brief, bacterial species (K. pneumoniae and S. aureus) at 1 × 10 7 CFU/ml with 70 μl of produced VBLE-MnO 2 NPs at a concentration of 250 μg/ml and incubating at 37°C for 24 h. Following that, the microbial cells were treated for an additional 30 min at 37°C with CellROX ® Green (5 μm). Following that, CLSM was utilized to acquire CLSM images at 485 nm absorption and 520 nm emission wavelengths. To assess microbial cells' ability to generate reactive oxygen species (ROS), the results of cells treated with NPs were compared to those treated with 1 mm H 2 O 2 (positive control) and untreated cells (negative control).

Antifungal Activity
The antifungal activity of the green synthesized VBLE-MnO 2 NPs was estimated on three mycological species, which include A. fumigatus (ATCC ® 13073™), Trichoderma harzianum (ATCC ® 32086™), and A. flavus (ATCC ® 9643™). A same antibacterial activity method as stated before in section 3.5 was performed, but seeding was performed using a Sabouraudgentamicin-chloramphenicol (SGC) fungus agar plate and the incubation temperature was maintained at 30°C. The antifungal activity was expressed in the form of log 10 reduction in bacterial growth and % killing using the following formulas: log l og log 10 10 10 here, CFU B and CFU A are the CFU of mycological strains before and after 24 h of incubation, respectively, with the treatment of sample solutions.

Anticancer Activity
The anticancer activity of the green synthesized VBLE-MnO 2 NPs was determined against the MCF-7 breast cancer cells following the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide] colorimetric protocol. The MCF-7 cancer cells were kept in Dulbecco's Modified Eagle's Medium (DMEM) in an incubator which was set at 5% CO 2 , 95% air, and 37°C. To obtain cell confluency up to 5 × 10 8 cells/well, the MCF-7 cells were grown for 24 h at 37°C in 100 μl of DMEM in a 96-well plate. After 50 μl of VBLE-MnO 2 NPs, plant extract and CH-MnO 2 NPs at a concentration of 1, 10, 20, 40, 60, 80, 100, and 120 μg/ml were added in each well separately containing cultured MCF-7 cells, and the plate was further incubated for 24 h at 37°C. The plate was then centrifuged to remove the supernatant and rinsed with PBS solution. A total of 15 μl of MTT labeling agent (0.5 mg/ml) was then poured into each well; the plate was then put in an incubator for 4 h at 37°C. 150 μl of DMSO was added to each well to solubilize the undissolved crystals of formazan. The absorption maxima of formazan product in each well were measured at 570 nm using a Varian Eclipse spectrophotometer. The percentage of cell viability was calculated using the following formula with the help of the following equation:

Live and Dead Staining Analysis
Further detection of cell viability utilizing the live and dead staining kit was investigated with the fluorescent staining technique. As already described above, the same experiments were repeated until MCF-7 cancer cells were treated with various samples concentration (10 μl of 120 μg/ml) and subsequently incubated. After incubation, staining solution at a 4 μg/ml concentration was added to each well and then incubated for 20 min at 37°C. Dead and live MCF-7 cells were analyzed with CLSM using an excitation wavelength of 493 nm and 350 for PI and Hoechst 33342 and an emission wavelength of 636 nm and 461 nm for PI and Hoechst 33342, respectively.

Antioxidant Activity in Terms of Linoleic Acid (%) Inhibition
The antioxidant activity of the green synthesized VBLE-MnO 2 NPs was evaluated according to the linoleic acid (%) inhibition method reported by . For this purpose, 100 μg/ml concentration of each sample (green synthesized VBLE-MnO 2 NPs, plant extracts, and chemically synthesized VBLE-MnO 2 NPs) was added to the solution mixture of 99.99% ethanol (10 ml), 0.2 M sodium phosphate buffer (pH 7.0, 10 ml), and linoleic acid (0.13 ml). With DI, the total amount of the resultant mixture was increased to 25 ml and then incubated for 360 h at 40°C. The thiocyanate technique was used to assess the extent of oxidation. Each sample solution was diluted by adding 0.2 ml of each sample solution in 10 ml of ethanol (75%). Then, 0.2 ml FeCl 2 (20 mm in 3.5% HCl) and 0.2 ml of aqueous ammonium thiocyanate solution (30%) were added, and then, the mixture was mixed for 3 min. Measurements of the absorption maxima were made at 500 nm wavelength. The percentage inhibition (% Inhibition) of linoleic acid was determined using the formula as: Absorbance of sample absorbance of contr = − ( ) Ascorbic acid was used as an external standard, and linoleic acid was used as a control without any treatment.

Cytobiocompatibility Analysis
The cytobiocompatibility of the green synthesized VBLE-MnO 2 NPs against the hMSC cell line in comparison with the CH-MnO 2 NPs and plant extract was evaluated via the MTT protocol as reported by Emam et al. (2017). The hMSC cells were kept in Dulbecco's Modified Eagle's Medium (DMEM) in an incubator which was set at 5% CO 2 , 95% air, and 37°C. To obtain cell confluency up to 5 × 10 8 cells/well, the hMSC cells were grown for 24 h at 37°C in 100 μl of DMEM in a 96-well plate. After 50 μl of green synthesized VBLE-MnO 2 NPs, plant extract and CH-MnO 2 NPs at a concentration of 120 μg/ml were added in each well separately containing cultured hMSC cells, and the plate was further incubated for 24 h at 37°C. The plate was then centrifuged to remove the supernatant and rinsed with PBS solution. A total of 15 μl of MTT labeling agent (0.5 mg/ml) was then poured into each well; the plate was then put in an incubator for 4 h at 37°C. A total of 150 μl of DMSO was added to each well to solubilize the undissolved crystals of formazan. The optical density (OD) of formazan product in each well was measured at 570 nm using a Varian Eclipse spectrophotometer. The percentage of cell viability was calculated using the following formula:

Statistical Analysis
All trials were conducted in triplicate, and the findings are given as mean ± standard deviation. To ascertain the statistical significance, we used ANOVA with a predetermined significance level (0.05).

Synthesis Mechanism
For the fabrication of VBLE-MnO 2 NPs, the leaf extract of V. betonicifolia was utilized as a reducing and capping agent. The formation of VBLE-MnO 2 NPs was visually tracked by observing the color change caused by the addition of a precursor to leaf extract. The reaction mixture's color shift from yellowish green to brownish indicated the formation of the required manganese dioxide NPs. This color shift occurred as a consequence of the nanoparticle's surface plasmon resonance action. Several reports demonstrate that the leaves extract of V. betonicifolia is a rich source of several biogenic phytomolecules, including alkaloids, flavonoids, tannins, phenolic compounds, saponins, and triterpenoids [14][15][16][17]. During the biosynthesis process, these phytomolecules might be functioned as reducing the manganese ions to zero-valent species via reduction and oxidation reaction with the production of keto form products. Further, other secondary metabolites (surfactants, proteins, alkaloids,

Characterization
XRD analysis was carried out to analyze the crystallinity of the VBLE-MnO 2 NPs synthesized using the leaves extract of V. betonicifolia. Figure 2A shows . Moreover, the XRD pattern indicates that the VBLE-MnO 2 NPs are highly crystalline, as evident from the intensity of the peaks. Figure 2B presents the TEM images of VBLE-MnO 2 NPs. The TEM image depicts that the synthesized VBLE-MnO 2 NPs are spherical with homogeneous dispersity. The particle size of the synthesized VBLE-MnO 2 NPs was estimated to be 10.5 ± 0.85 nm using Zetasizer Dynamic Light Scattering, as shown in Figure 2C. To determine the chemical composition of the VBLE-MnO 2 NPs, the EDX analysis was then conducted. Figure 2D shows the EDX pattern. EDX spectra indicate four characteristics peaks corresponding to carbon, nitrogen, oxygen, and manganese at 0.27 kev, 0.39 kev, 0.52 kev, and 5.8 kev, respectively. A small peak at 0.63 kev attribute to Mn is also evident in EDX spectra (Panahi-Kalamuei et al., 2016;Srither et al., 2016;Ogunyemi et al., 2019). The EDX peaks (C and N) might be attributed to the adsorption of secondary metabolites from V. betonicifolia leaves extract on the surface of VBLE-MnO 2 NPs (Ciorîță et al., 2020). Thus, these characterization findings confirmed the effective synthesis of VBLE-MnO 2 NPs using a leaf extract of V. betonicifolia.

Antibacterial Activity
Antibacterial activity of VBLE-MnO 2 NPs was determined in terms of log 10 reduction and % killing efficiency of bacterial strains compared to leaves extract of V. betonicifolia and CH-MnO 2 NPs. The results are presented in Figures 3A-C. The outcomes have been shown that the synthesized VBLE-MnO 2 NPs displayed 4.14 ± 0.03 and 4.65 ± 0.07 log 10 reductions in CFU of K. pneumoniae and S. aureus, respectively, with more than 80% killing efficiency. On the other hand, CH-MnO 2 NPs demonstrated the least antibacterial activity (log 10 reductions 3.14 ± 0.04 and 3.33 ± 0.08 against K. pneumoniae and S. aureus, respectively) than VBLE-MnO 2 NPs, as shown in Figures 3A,B. It is worth noting that the leaves extract of V. betonicifolia has shown significant antibacterial behavior (log 10 reductions >2.35) and more than 45 percent killing performance against all bacteriological species tested. This indicates that the leaves extract of V. betonicifolia possesses pharmacologically important phytomolecules capable of killing bacterial strains effectively (Feyzabadi et al., 2017;Rizwan et al., 2019). Additionally, we conducted an ANOVA test on the antibacterial findings, which showed a significant difference of p < 0.005.

LIVE and DEAD Staining Assay
LIVE and DEAD staining assay was used to evaluate the interaction of synthesized VBLE-MnO 2 NPs with cells and subsequent cell death upon labeling with Hoechst 33342 and PI. The permeability of the bacterial membrane to these dyes is dependent on the cellular membrane's potential, which allows for the differentiation of alive and dead cells. Hoechst 33342 is a membrane-permeant dye can stain both alive and dead cells by interlacing DNA, while PI is a membraneimpermeant dye that permeates only through dead cells' perforated membranes and can stain only dead cells (Arakha et al., 2015;Ramalingam et al., 2016). As illustrated in Figures 4A,C, the untreated K. pneumoniae and S. aureus, stained only with Hoechst 33342, suggesting that they were intact and alive. At the same time, VBLE-MnO 2 NPs treated cells fluoresced red (Figures 4B,D). This revealed that VBLE-MnO 2 NPs triggering cell death had an effect on the integrity and permeability of the cell membrane.

Reactive Oxygen Species Generation in Bacteria Treated With VBLE-MnO 2
Oxidative stress caused by intracellular ROS production has been shown to destroy microbial strains (Kim et al., 2007). Metal nanoparticles (NPs) interact with bacteria to produce ROS, which can lead to oxidative stress inside the cell and the destruction of organelles and biomolecules. Figure 5 depicts the results of the CellROX ® Green test, which was used to assess oxidative stresses in microbial cells following treatment with VBLE-MnO 2 NPs. No intracellular ROS species were produced in either bacterial cell under control. Both bacteria treated with VBLE-MnO 2 produced ROS comparable to that produced by H 2 O 2 . These findings suggest that one explanation for the outstanding antibacterial activity of the VBLE-MnO 2 produced is the production of ROS, which causes bacterial cells to die. Graphical presentation of ROS production mechanism in bacterial cells due to VBLE-MnO 2 NPs is shown in Figure 5.

Antibacterial Mechanism
Additionally, the superior antibacterial action of VBLE-MnO 2 NPs can be due to the synergy influence of the nanoparticle's physical characteristics and the adsorption of biologically active phytomolecules from the leaves extract of V. betonicifolia on their surface (Huang et al., 2011;Khan et al., 2018Khan et al., ,b, 2021a. The results were further demonstrated that the synthesized VBLE-MnO 2 NPs appeared more active toward the Gram-positive in contrast to that of Gram-negative bacteriological species. This may be due to structural and compositional variations between Gram-negative and Gram-positive bacterial strains' cell walls (Figures 6A,B; Bindhu and Umadevi, 2014;Muthukumar et al., 2016;Boomi et al., 2019). Manjula et al. and Kunkalekar et al. were also reported the same more inhibitory effect of MnO 2 NPs toward Grampositive than Gram-negative bacteria (Kunkalekar et al., 2013;Manjula et al., 2019). Numerous reports have shown that the antibacterial effect of nanomaterials is mostly due to physical (e.g., lipid molecule disintegration) and chemical (e.g., oxidative stress) deterioration (Du et al., 2020). The synergy of antibacterial activity was defined in this study using a two-step approach: (1) generation of reactive oxygen species (Figures 5, 6C) and (1) membrane damage, leakage of electrolytes and intracellular contents, and decrease in ATPase activity, all of which contribute to bacterial death (Figures 4, 6C).

Antifungal Activity
In contrast to leaves extract of V. betonicifolia and CH-MnO 2 NPs, the antifungal activity of synthesized VBLE-MnO 2 NPs was determined in terms of log 10 reduction and % killing efficiency of mycological strains. Figures 7A,B illustrate the findings. The results indicated that the synthesized VBLE-MnO 2 NPs significantly reduced the CFU of A. flavus, T. harzianum, and A. fumigatus by 4.05 ± 0.06, 4.32 ± 0.07, and 4.63 ± 0.05 log 10 reductions, respectively, with a killing efficiency of more than 82 percent. CH-MnO 2 NPs, on the other hand, demonstrated significantly lower antifungal activity than VBLE-MnO 2 NPs, as shown in Figures 7A,B. Furthermore, we conducted an ANOVA test on the antifungal activity results, which exhibited a significant difference of p < 0.002. It is worth noting that the leaves extract of V. betonicifolia also demonstrated substantial antifungal activity and percent killing efficiency against all tested mycological strains. This indicates that the V. betonicifolia leaf extract contains biologically active phytomolecules that are particularly effective at destroying fungal strains (Katoch et al., 2017). Additionally, the superior antifungal activity of VBLE-MnO 2 NPs can be due to the synergistic impact of the nanoparticle's physical properties and the adsorbed biologically active phytomolecules from the leaves extract of V. betonicifolia on their surface. The similar antifungal results were also reported with the green synthesized MnO NPs using leaf extract of Abutilon indicum by .

Biofilm Inhibition Investigations
The biofilm inhibition activity of VBLE-MnO 2 NPs was evaluated against infectious bacterial and mycological species in contrast to V. betonicifolia leaves extract and CH-MnO 2 NPs. Figures 8A,B illustrate the findings. The findings indicate that the VBLE-MnO 2 NPs exhibited substantial biofilm inhibitory activity, inhibiting the production of biofilms of both bacterial and mycological strains. Although CH-MnO 2 NPs inhibited the production of biofilms in both microbial species but were less than VBLE-MnO 2 NPs synthesized with V. betonicifolia leaves extract. Moreover, the V. betonicifolia leaves extract also demonstrated good biofilm inhibition performance, as evident from Figures 8A,B. In addition, we performed an ANOVA test on the biofilm inhibition activity data against both of fungal and bacterial strains, which revealed a significant difference of p < 0.002 and p < 0.001, respectively. The remarkable biofilm inhibition efficiency of the synthesized VBLE-MnO 2 NPs may be a result of the synergy between their physical properties and the incorporation of phytomolecules from V. betonicifolia leaves extract on the nanoparticle's surface.

Cytotoxic Potential Against MCF-7 Carcinoma Cells
The cytotoxic potential of VBLE-MnO 2 NPs was determined by comparing them to V. betonicifolia leaves extract and CH-MnO 2 NPs. The findings indicated that all samples exhibited dose-dependent therapeutic effectiveness ( Figure 9A). The maximum inhibitory effects on MCF-7 melanoma cells were observed when all samples were concentrated to 120 μg/ml. The VBLE-MnO 2 NPs displayed excellent cytotoxic activity in comparison with V. betonicifolia leaves extract and CH-MnO 2 NPs at all dose levels. The extraordinary cytotoxic activity of the produced VBLE-MnO 2 NPs might be attributed by a synergy between their physical characteristics and the inclusion of phytomolecules from V. betonicifolia leaves extract on the NP's surface. It is worth mentioning that the leaves extract of V. betonicifolia also exhibited effective cytotoxic activity against MCF-7 carcinoma cells. This shows that the leaves extract of V. betonicifolia contains phytomolecules of pharmacological   Ciorîță et al. (2020) but comparable to the NPs reported by . The similar dose-dependent cytotoxic activity was also reported by .

Live and Dead Staining
CLSM was further used to confirm the cytotoxicity against MCF-7 cancerous cells utilizing the live and dead fluorescence staining experiment. Figures 10A-D

Antioxidant Activity
Antioxidant activity of the newly synthesized VBLE-MnO 2 NPs was investigated in comparison with the leaves extract of V. betonicifolia, CH-MnO 2 NPs, and external standard (ascorbic acid). Figure 11A illustrates the findings. The anti-linoleic acid peroxidation activity of newly synthesized VBLE-MnO 2 NPs was superior (84.94 ± 0.77%) to that of V. betonicifolia leaves extract and CH-MnO 2 NPs, although a little less than that of ascorbic acid (90.57 ± 1.21%). On the other hand, CH-MnO 2 NPs exhibited the lowest antioxidant function, exhibiting the lowest percentage of anti-linoleic acid peroxidation (61.61 ± 0.79%). Additionally, the leaves extract of V. betonicifolia demonstrated superior antioxidant function by inhibiting linoleic acid peroxidation (69.37 ± 1.37%) as compared to CH-MnO 2 NPs. These findings suggested that V. betonicifolia leaves extract contains a high concentration of natural antioxidants (Muhammad et al., 2013b;Rizwan et al., 2019). Furthermore, the inclusion of phytomolecules from V. betonicifolia leaves extract on the nanoparticle's surface could be responsible for the VBLE-MnO 2 NPs' superior antioxidant activity. We performed an ANOVA test on the antioxidant findings and determined that they were statistically significant at p < 0.004. The similar enhanced antioxidant activity of the green synthesized NPs was also reported by ; Shahid et al. (2021).

Biocompatibility Evaluation
The biocompatibility of VBLE-MnO 2 NPs was assessed with the hMSC cells in vitro compared to the V. betonicifolia leaves extract and CH-MnO 2 NPs. The results are expressed as a percentage of cell viability, as shown in Figure 11B.  (Muhammad et al., 2012(Muhammad et al., , 2013cRizwan et al., 2019). We used an ANOVA test to determine the statistical significance of the biocompatibility findings and discovered a p < 0.007 significance level. We next examined the morphological changes in hMSC cells treated with VBLE-MnO 2 NPs, plant extract, and CH-MnO 2 NPs at a 120 μg/ml concentration using an inverted microscope. The inverted micrograph of hMSC cells is shown in Figure 11C. The photographs demonstrate that following treatment with plant extract and VBLE-MnO 2 NPs, the morphology of hMSC cells remained comparable to that of the control (untreated cells). On the other hand, CH-MnO 2 NPs caused toxicity in hMSC cells, reducing their volume and cytoplasm, and altering their shape. The viability of cells and the inverted microscopy findings were found to be consistent. As a result, it can be inferred that phytomolecules contained in the leaves extract of V. betonicifolia may be responsible for the VBLE-MnO 2 NPs' enhanced cytobiocompatibility. The similar enhanced biocompatibility of the green synthesized NPs with various normal cell lines was also reported by Ciorîță et al. (2020) and Khan et al. ( ,b, 2021b.

CONCLUSION
The manganese dioxide NPs (VBLE-MnO 2 NPs) were synthesized using the leaves extract of V. betonicifolia very first time, in which the plant's secondary metabolites function as both reducing and capping agents. The synthesized VBLE-MnO 2 NPs were successfully characterized with different spectroscopic techniques. The synthesized VBLE-MnO 2 NPs were investigated for different biological activities (antioxidant, cytotoxicity, antibacterial, antifungal, and biofilm inhibition). The results were demonstrated that the synthesized VBLE-MnO 2 NPs presented excellent antibacterial, antifungal, and biofilm inhibition performance against all the tested microbial species compared to plant leaves extract and commercially purchased chemically synthesized manganese dioxide NPs (CH-MnO 2 NPs). Moreover, they also exhibited significant antioxidant potential, which was comparable to the external standard; however, it was higher than plant leaves extract and CH-MnO 2 NPs. The synthesized CH-MnO 2 NPs displayed good cytobiocompatibility with hMSC cells compared to CH-MnO 2 NPs. The enhanced antioxidant, cytobiocompatibility, antibacterial, antifungal, biofilm inhibition, and cytotoxic efficacy of VBLE-MnO 2 NPs as compared to CH-MnO 2 NPs might be attributed to the synergistic effect of the nanoparticle's physical properties and the adsorbed biologically active phytomolecules from the leaves extract of V. betonicifolia on their surface. Thus, our work offers a unique environmentally sustainable technique for the manufacture of nanomaterials bestowed with enhanced and/or additional therapeutic properties obtained from their herbal sources. Furthermore, more study should be conducted to determine the efficacy and dose response biocompatibility of VBLE-MnO 2 NPs in therapeutic interventions. The VBLE-MnO 2 NPs synthesized in this research could be utilized to provide antibacterial coatings for medical devices, such as catheters, tubing, sensors, and bandages, thereby lowering the incidence of pathogenic bacteriological and mycological infections induced by biomaterials and medical implants.

DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

AUTHOR CONTRIBUTIONS
HL and XZ: conceptualization, methodology, software, validation, formal analysis, and investigation. SK, WL, and LW: resources, data curation, writing-original draft preparation, writingreview and editing, visualization, supervision, and project administration. WL and LW: funding acquisition. All authors have read and agreed to the published version of the manuscript.